India Ratings affirms Jubilant Life Sciences’ long-term issuer rating at ‘A+’

11 Dec 2013 Evaluate

Credit rating agency, India Ratings & Research has affirmed Jubilant Life Sciences’ long-term issuer rating at ‘A+’ with stable outlook. The affirmation reflects the company’s healthy business risk profile, supported by its strong domestic market position in custom research and manufacturing services coupled with its geographically diversified revenue streams.

Jubilant Life Sciences is a global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.

As on September 30, 2013, Jubilant Life Sciences had a total of 676 filings for formulations of which 218 have been approved in various regions of the world. This includes 58 ANDAs filed in the US and 48 Dossier filings in Europe.

 

Jubilant Pharmova Share Price

1139.75 8.90 (0.79%)
22-Nov-2024 13:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1787.25
Dr. Reddys Lab 1213.85
Cipla 1488.65
Lupin 2061.95
Zydus Lifesciences 948.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.